SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Merck
Merck
Page 5 of 9
Health
Why Pfizer and Merck Stock Both Slumped After Their Earnings Reports
By
Sy Mukherjee
May 1, 2018
Health
Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer
By
Sy Mukherjee
April 16, 2018
Health
Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
By
Sy Mukherjee
April 12, 2018
Health
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
By
Sy Mukherjee
April 9, 2018
Health
Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It
By
Sy Mukherjee
April 6, 2018
Health
Alzheimer’s Cases Are Expected to Double By 2060 and We’re Not Ready for It
By
Sy Mukherjee
December 7, 2017
Health
We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By
Sy Mukherjee
November 2, 2017
Health
Could a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?
By
Sy Mukherjee
October 24, 2017
Tech
Tanium CEO’s Refreshingly Honest Take on the State of Internet Security
By
Robert Hackett
October 21, 2017
Tech
This Google, Microsoft, Samsung-Targeting ‘CCleaner’ Attack Sets an Insidious Trend
By
Robert Hackett
September 23, 2017
Health
Tons of Companies Ditched Trump After Charlottesville. But Merck Got the Biggest Boost
By
Sy Mukherjee
August 23, 2017
Leadership
These 18 CEOs Had Strong Words for President Trump’s Charlottesville Response
By
Rachel Lewis
August 17, 2017
Health
Merck’s CEO Isn’t the First Biopharma Chief to Tangle With Trump Over Race
By
Sy Mukherjee
August 14, 2017
Leadership
CEOs on Trump’s Council Speak Out. Others Stay Silent on Charlottesville
By
Beth Kowitt
August 14, 2017
Leadership
Merck CEO Quits Trump Council Over President’s Charlottesville Response
By
Julia Zorthian
August 14, 2017
Most Popular
Success
Gen Z is reviving this boring job that millennials and boomers abandoned—and it's helping them land six-figure careers...
By
Preston Fore
North America
'The frustration is overwhelming': Soybean farmers feel betrayed as Argentina blows a hole in rural America’s $47...
By
Sasha Rogelberg
Economy
Markets sold off after Powell said six words investors don’t want to hear: ‘Equity prices are fairly highly valued’
By
Jim Edwards